Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/11556
|
| Title: | Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells |
| Other Titles: | Laminin γ2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin α3-dependent uptake by lymphatic endothelial cells |
| Authors: | Wang, SH;Liou, GG;Liu, SH;Chang, JS;Hsiao, JR;Yen, YC;Chen, YL;Wu, WL;Chang, JY;Chen, YW |
| Contributors: | National Institute of Cancer Research |
| Abstract: | Oral squamous cell carcinoma (OSCC) LN1-l cells previously showed greater capacities for lymphangiogenesis and lymph node metastasis compared to their parental OEC-M1 cells, in addition to an ability to enhance the migration and tube formation of lymphatic endothelial cells (LECs). Purified by a series of differential centrifugations and characterized using electron microscopy, dynamic light scattering, and western blot, LN1-1 cell-derived extracellular vesicles (LN1-1 EVs) were shown to promote LEC migration, tube formation, and uptake by LECs more effectively than did OEC-M1 cell-derived EVs (OEC-M1 EVs). Using stable isotope labeling with amino acids in cell culture/liquid chromatography-tandem mass spectrometry based proteomic platform, the laminin-332 proteins, including laminin alpha3, beta3, and gamma2, were validated as highly expressed proteins in LN1-1 EVs. Clinically, a higher level of laminin-332 was detected in plasma EVs from OSCC patients with lymph node metastasis than in both healthy controls and OSCC patients without lymphatic metastasis, suggesting EV-borne laminin-332 as a novel and non-invasive biomarker for the detection of lymph node metastasis in OSCC. The knockdown of laminin gamma2 and inhibition by anti-laminin-332 neutralizing antibodies impaired LN1-1 EV-mediated LEC migration, tube formation, and uptake by LECs. Importantly, laminin gamma2-deficient EVs showed a reduced ability to drain into lymph nodes in comparison with the control EVs. Additionally, the laminin 332/gamma2-mediated EV uptake was dependent on integrin alpha3 but not beta1, beta4 or alpha6. Collectively, the uptake of laminin gamma2-enriched EVs by LECs enhanced in vitro lymphangiogenesis and EV-borne laminin-332 is thus a viable biomarker for OSCC. This article is protected by copyright. All rights reserved. |
| Date: | 2019-06-01 |
| Relation: | International Journal of Cancer. 2019 Jun 1;144(11):2795-2810. |
| Link to: | http://dx.doi.org/10.1002/ijc.32027 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0020-7136&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000467099500017 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85059918171 |
| Appears in Collections: | [陳雅雯] 期刊論文
[張書銘] 期刊論文
[張俊彥] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB30485433.pdf | | 2373Kb | Adobe PDF | 379 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
